Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 479 (OTC: CSUI) (OTCQB: BVNNF) (TSXV: KHRN) (OTCQX: CURLF) (OTC: PHCG)
Today's podcast sponsored by Cannabis Suisse Corp. (OTC: $CSUI), a fully licensed cannabis cultivation and distribution company in Switzerland
Delta, Kelowna, BC - October 9, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 479 (OTC: CSUI) (OTCQB: BVNNF) (TSXV: KHRN) (OTCQX: CURLF) (OTC: PHCG)
Today's podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today's podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's facilities for producing cannabis are based in Dietikon, Switzerland, and contain the art surveillance equipment to enable an around the clock webcast. Cannabis Suisse grows high quality, organic cannabis with sustainable, all-natural principles. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse proprietary trademarked MoldStandard is a quantitative microbiology method for analyzing yeast and mold counts in harvested cannabis plants. Cannabis Suisse proprietary trademarked CannaMec is a method for quantifying and removing residual solvents during packaging and storage of CBD products. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.
In today's podcast we look at a few public and private company announcements.
Cannabis Suisse Corp. (OTC:CSUI), a fully licensed Swiss cannabis cultivation and distribution company for recreational tobacco products and medical CBD oils, announced the first product from its Swiss4Life CBD product line created for the upcoming launch on Shopify.
The new brand concept is based on the Company's mission to improve the quality of life of its customers by providing them with high-grade CBD products.
The Swiss4Life first product will be one fluid ounce (30ml) available in two flavors: Creme de Menthe and Cherry Vanilla. It will be a Broad Spectrum Oil with different CBD concentrations of 1500 mg, 2500 mg, 3500 mg. All of the oil products will include graduated droppers for accurate dosing so consumers will have the ability to choose the dosage that best suits them personally.
Swiss4Life Broad Spectrum Oil will contain 0% THC, which means it will effectively perform therapeutic functions without causing adverse reactions. High quality hemp seed oil will be the carrier in the new product saving all the important nutrients, including protein, vitamins, fatty acids and minerals. Omega 3-6-9 is a complex of the most important unsaturated fatty acids for human health.
COO Alain Parrik explained. "Since the human body does not produce these substances on its own, it needs their regular supply from other sources to maintain one's physical and mental health."
Swiss4Life Broad Spectrum Oil will be made of USA hemp only, will contain no THC, GMO or Gluten. All the products will be manufactured by an FDA Registered Entity, Silver Shadow Ventures, LLC and will be tested by an independent third-party laboratory.
BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) announced today that its wholly owned subsidiary, Pure Therapy Products Corp. has generated C$1.53 million in unaudited gross revenue over the first nine months of 2020 and a net profit of C$104,000. Pure Therapy has also acquired more than 3,000 new customers over the same period. The acquisition will now provide BevCanna with a steady and growing revenue stream.
Recently acquired by BevCanna, Pure Therapy is a direct-to-consumer e-commerce company selling a range of natural health products, including nutraceutical and hemp-based cannabidiol products throughout North America and Western Europe. Pure Therapy's extensive catalogue of formulations are proprietary and professionally crafted based on market demand and product quality. Every product manufactured is third-party tested for purity and manufactured in GMP (good manufacturing practices) certified facilities.
"Our goal with the Pure Therapy acquisition was to stimulate strong revenue growth and accelerate our Q4 sales by adding new products, investing in customer acquisition and retention programs and leveraging the platform's current mix of subscription-based and traditional sales revenue models to build a strong recurring revenue stream," noted John Campbell, Chief Strategic Officer for BevCanna. "We're very pleased with the progress that we've made over our first month of ownership and we are on track for a very strong Q4 and 2021."
The Pure Therapy acquisition has also provided BevCanna with a proven e-commerce brand and platform to expand and launch its own proprietary hemp-based products directly into the global health and wellness market, including the burgeoning U.S. CBD market. The brand has a substantial existing customer base and a powerful direct sales platform. Pure Therapy brings an extensive list of approximately 23,000 customers that it has acquired since 2017. The brand achieved unaudited calendar year 2019 gross revenues of C$4.78M and a net profit of C$.22 million.
Capital constraints under the previous ownership resulted in an interim revenue shortfall in early 2020 for the Pure Therapy brand, but BevCanna's purchase and subsequent strategic investments and improvements have positioned the platform to be on track to deliver strong revenue in the fourth quarter, with a forecasted annualized run rate of C$6 million. BevCanna projects immediate growth in the brand beyond 2020, achieved through new product integration and by accelerating the growth of the existing natural health products line, leveraging the extensive e-commerce marketing expertise of the existing Pure Therapy team. The Company forecasts a gross revenue of C$7.28 million and net profit of C$.26 million for 2021.
Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF), a vertically integrated cannabis leader with core operations in Latin America and Europe, provided a corporate update on its global medical cannabis operations, including accelerating growth of 450% in its Colombian medical cannabis prescriptions, first sales in the UK, and entry into the Peruvian market.
"We have been saying for some time that we are in the execution phase of our business strategy. Measurable developments over recent weeks substantiate our approach and importantly, the ability of our team to execute on the plan. Despite the impact of the global pandemic, our medical cannabis sales are seeing accelerated growth in Colombia, with more than 3,500 prescriptions now filled. In addition, we supplied medical cannabis to Project Twenty21 participants in the UK, and began medical cannabis sales in Peru. Further, as a result of our timely adoption of technology-based solutions, clinic consultations returned to pre-pandemic monthly levels in September," comments Alvaro Torres, Khiron CEO and Director.
Some of Khiron's recent achievements included:
- Khiron reaches more than 3,500 medical cannabis prescriptions filled
- Medical cannabis prescriptions increased by over 450% in Q3, compared to Q2 of 2020
- Khiron's clinics exceeded 9,000 monthly patient consultations in September, marking a return to pre-pandemic monthly levels, supported by the launch of telehealth consultations
- Khiron was declared a National Strategic Project by the Government of Colombia in September, accelerating its ability to register and introduce new SKUs in the medical cannabis and consumer-packaged goods categories
- Khiron became the first company to sell medical cannabis in Peru, introducing its new CBD brand AlexinTM, sold under its previously announced agreement with Farmacia Universal, the largest compounding pharmacy in Peru
- In September, the Company signed partnerships with 15 clinics and health centres in Colombia, extending education and sales reach further across the country
- As the exclusive LatAm provider, Khiron began sales of medical products to patients participating in Project Twenty21 in the UK, the largest medical cannabis patient registry in Europe
- Medical cannabis e-learning platform introduced in UK in partnership with the Medical Cannabis Clinicians Society, an independent, clinician-led organization sharing guidance to lead the medical cannabis conversation in the UK
- Khiron's e-learning program accelerates medical cannabis knowledge for doctors participating in Project Twenty21, which now includes over 9,000 registrants
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), a leading vertically integrated cannabis operator in the United States, today unveiled Curaleaf NANO Drops, a new addition to its lineup of products utilizing nanoemulsion technology. The Company, whose Select brand recently reached $1 million in sales in just one month in Florida, has launched a new precision-calibrated sublingual tincture which is infused with small, water-soluble cannabinoids, resulting in a faster, more efficient cannabinoid delivery system.
"Curaleaf NANO Drops are unique in their versatility and offer a great alternative for customers interested in a faster onset and more efficient dosing product," said Joe Bayern, President of Curaleaf. "After the successful launch of Curaleaf Sublingual Tablets, we are excited to expand our portfolio of products utilizing this technology to bring customers more options when it comes to their cannabis choices."
Unlike oil-based medium-chain triglyceride (MCT) tinctures, Curaleaf NANO Drops are formulated to immediately dissolve directly in the mouth. The science behind Curaleaf NANO Drops is a major upgrade to traditional MCT's, as they deliver a faster onset and shorter duration due to the water-soluble nature of the technology. Curaleaf NANO Drops join the Company's first to Florida market Sublingual Tablets, providing patients another way to confidently manage their treatment plan.
Curaleaf NANO Drops are available in a slim 30ML tincture bottle and deliver a precise 5MG THC dose per 1ML drop. Drops are available unflavored or in lime or grapefruit varieties. The tincture is the second product Curaleaf has developed using its cutting-edge NANO technology; earlier this year the company introduced Curaleaf and Select NANO Gummies in five other states including Arizona, California, Maine, Massachusetts, and Nevada. Curaleaf NANO Drops will be available exclusively at all Curaleaf Florida locations at launch, with plans to expand to other states.
Pure Harvest Corporate Group, Inc. (OTC: PHCG), an emerging cannabis and hemp-CBD holding company, is pleased to announce it has acquired all of the assets of Solar Cultivation Technologies, Inc. ("SCT"), a Denver-based solar company focused on bringing solar to the cannabis industry in an effort to minimize the industry's carbon footprint. This acquisition will allow PHCG to implement SCT's solar, storage, and intelligent distribution technology throughout its operations in addition to providing these technologies to other operators in the cannabis industry.
"We are extremely excited to acquire SCT's assets and technology and are confident that this acquisition will position PHCG to become an environmental leader within the cannabis space," said Matthew Gregarek, CEO of Pure Harvest Corporate Group. "We understand that the industry's carbon footprint is a tremendous issue and we believe that we now have the tools to make a serious contribution towards sustainability in the cannabis industry."
"I've been very impressed with Pure Harvest as we've worked with them to create its solar powered dispensary in Dumont," said Nick Brait, CEO of Solar Cultivation Technologies. "Naturally, we leapt at the opportunity to become a part of the Pure Harvest family of companies and add our abilities and technology to its expanding portfolio of assets. We believe that our two companies are well aligned and have the potential to make a dramatic impact on the cannabis industry's energy requirements and carbon emissions."
Once again, today's podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining the AI Eye.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
Disclosure: Cannabis Suisse Corp. (OTC: CSUI),is a paid featured company on Investorideas.com
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Download our Mobile App for iPhone and Android